Celltrion Inc.

South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

South Korea’s major industries, especially the petrochemical and auto parts sectors, are suffering from surging global commodity prices, a wea...

SK Group, South Korea’s No. 2 conglomerate, joined hands with TerraPower, an advanced nuclear power venture founded by billionaire Bill Gates,...

South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...

SK Group, South Korea’s third-largest conglomerate, has geared up its electric vehicle chip business development with the acquisition of a loc...

CJ Corp. launched an artificial intelligence center Wednesday, which it hopes will lead the conglomerate's digital innovation. The new CJ AI Cente...

US hedge fund Dalton Investments LLC has urged SK Inc., the holding company of South Korea’s SK Group, to focus more on share buybacks and can...

South Korea’s major companies are in a sticky situation over their businesses in Russia following its invasion of Ukraine. Governments in the ...

South Korean companies had dreamed of a post-COVID-19 earnings recovery as the globe geared up for economic reopening. But their hopes are now dampe...

South Korean companies are revising their business plans for this year as soaring oil prices slam Asia’s fourth-largest economy. Inflation is ...

South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...

EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...

As South Korean securities regulators are moving to tighten their grip on the growing trend of splitting up businesses and listing the spun-off arms...

South Korea’s major companies are showcasing robots, mobility and the metaverse rather than cutting-edge models of their conventional products...

A Korean startup about a year old has succeeded in creating a microchip that speeds up trading by a few microseconds -- a huge difference in the w...

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

South Korea’s corporate sector has seen record deals through mergers and acquisitions, tie-ups and spin-offs this year, as big companies and s...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Hopes for improving corporate earnings are rising as countries around the world are relaxing their anti-COVID-19 measures, but South Korean companie...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...

SK Inc., the holding and investment company of South Korea’s SK Group, plans to invest 120 billion won ($102 million) in China’s Lingbao...

South Korean companies are emerging as big buyers in the global mergers and acquisitions (M&A) markets. They are actively looking for future gro...

SK Inc., the investment arm of South Korean conglomerate SK Group, and private equity firm STIC Investment Inc., have invested a combined 65 billion...

South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...

Investors are selling technology stocks in a major Asian economy on regulatory worries just as one of the country’s biggest online payment com...

South Korean software and ICT conglomerate Hancom Group will be the first private company in the country to launch a micro-satellite, or a satellite...

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...